We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNCE
13151
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$61K ﹤0.01%
18,800
-20,300
-52% -$71.1K
AMPE
13152
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$61K ﹤0.01%
122
+48
+65% +$22.3K
NAVB
13153
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$61K ﹤0.01%
35,100
+3,700
+12% +$6.23K
CETX icon
13154
Cemtrex
CETX
$4.25M
0
CRVO icon
13155
CervoMed
CRVO
$23.9M
$60K ﹤0.01%
1,559
-456
-23% -$19K
HDSN
13156
Hudson Technologies
HDSN
$254M
$60K ﹤0.01%
17,103
-35,915
-68% -$120K
MIST icon
13157
Milestone Pharmaceuticals
MIST
$138M
$60K ﹤0.01%
+10,466
New +$59K
NEXT icon
13158
NextDecade
NEXT
$1.79B
$60K ﹤0.01%
+21,635
New +$68.2K
TGB
13159
CALL
Trekor Metals
TGB
$2.48B
$60K ﹤0.01%
31,900
+13,900
+77% +$25K
VYGR icon
13160
PUT
Voyager Therapeutics
VYGR
$183M
$60K ﹤0.01%
22,700
-110,800
-83% -$360K
YARW
13161
CALL
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$60K ﹤0.01%
48
+11
+30% +$21.3K
XFOR icon
13162
PUT
X4 Pharmaceuticals
XFOR
$375M
$60K ﹤0.01%
+377
New +$62K
IMBI
13163
CALL
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$60K ﹤0.01%
+10,500
New +$67.4K
CTIC
13164
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$60K ﹤0.01%
20,200
-11,000
-35% -$30K
JG
13165
PUT
Aurora Mobile
JG
$33.4M
$59K ﹤0.01%
1,755
-615
-26% -$27.5K
LGMK
13166
CALL
DELISTED
LogicMark
LGMK
$59K ﹤0.01%
29
-31
-52% -$105K
MYPS icon
13167
PUT
PLAYSTUDIOS Inc
MYPS
$77.9M
$59K ﹤0.01%
13,000
-4,800
-27% -$27K
SCOR icon
13168
PUT
Comscore
SCOR
$106M
$59K ﹤0.01%
750
-1,715
-70% -$136K
VNRX icon
13169
VolitionRx Ltd
VNRX
$8.65M
$59K ﹤0.01%
+954
New +$60.4K
WATT icon
13170
Energous
WATT
$77.6M
$59K ﹤0.01%
47
-16
-25% -$22.9K
TECX
13171
PUT
Tectonic Therapeutic
TECX
$529M
$59K ﹤0.01%
+883
New +$72.5K
FACA.WS
13172
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$59K ﹤0.01%
+56,427
New +$64K
TMBR
13173
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$59K ﹤0.01%
1,286
+754
+142% +$37K
LUB
13174
DELISTED
Luby's Inc.
LUB
$59K ﹤0.01%
+14,199
New +$57.8K
BFRA
13175
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$59K ﹤0.01%
10,716
-2,475
-19% -$14.6K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.